Literature DB >> 25273499

Hysteria around the world.

Antonio Carota1, Pasquale Calabrese.   

Abstract

In the 20th century the term hysteria declined and the interest in the hysteria-related diseases decreased in comparison to the florid period of studies that was inspired by Charcot's legacy in the second half of the 19th century. Scientific interest has once again increased in the 21st century, and dissociative and somatoform disorders (previously indicated as hysteria or hysterical neurosis) have come to be regarded as conditions that are known to be much more prevalent than formerly estimated. Available current epidemiological data from several countries on different continents (adopting DSM criteria for diagnosis) suggest not only that the prevalence is probably similar, but also that there is a consistency in their clinical manifestation around the world and across different cultures, social classes, and institutional settings. In line with this uniformity, and also with Charcot's concept of hysteria as a functional disorder, neuroimaging studies suggest that for some of these disorders, there might be some changes of neural connectivity in specific pathways at the origin of the behavioral aspects. Only large-scale multidisciplinary transcultural studies can improve the research and the development of therapeutic interventions for these disorders.

Entities:  

Mesh:

Year:  2014        PMID: 25273499     DOI: 10.1159/000360062

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  2 in total

1.  Resignation Syndrome: Catatonia? Culture-Bound?

Authors:  Karl Sallin; Hugo Lagercrantz; Kathinka Evers; Ingemar Engström; Anders Hjern; Predrag Petrovic
Journal:  Front Behav Neurosci       Date:  2016-01-29       Impact factor: 3.558

2.  Gender differences in the prevalence and impact factors of hysterical tendencies in adolescents from three eastern Chinese provinces.

Authors:  Qinglin Cheng; Li Xie; Yunkai Hu; Jinfeng Hu; Wei Gao; Yongxiang Lv; Yong Xu
Journal:  Environ Health Prev Med       Date:  2018-02-07       Impact factor: 3.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.